Results 151 to 160 of about 2,539,381 (235)

Open access publishing in gastroenterology: good for the researcher and good for the public! [PDF]

Frontline Gastroenterol, 2020
Rej A, Menic N, Nyamali I, Punnamkuzhy JM, Whelpdale P, Sanders DS, Kurien M.   +6 more
europepmc   +1 more source

What is the Cost of Publishing an Open Access Journal?

Partnership: The Canadian Journal of Library and Information Practice and Research, 2019
Jessica Lange
doaj   +1 more source

Reprogramming tumor cells with LCOR mRNA nanotherapy to enhance immunotherapy

Molecular Oncology, EarlyView.
LCOR (Ligand‐dependent corepressor) mRNA encapsulated in polymeric nanoparticles restores LCOR activity in tumor cells, constraining aggressive tumor cell states and increasing tumor immunogenicity. This reprogramming makes tumor cells more vulnerable to T‐cell attack and enhances their response to immune‐checkpoint immunotherapy.
Gabriel Serra‐Mir, Elena Haro‐Martínez, Sandra Blasco‐Benito, Chiara Cannatà, José Ángel Palomeque, Anna López‐Plana, Maria Sanz‐Flores, Marc Sabartés, Cristina Fornaguera, Toni Celià‐Terrassa   +9 more
wiley   +1 more source

Effects of open access publishing on article metrics in Neuropsychopharmacology. [PDF]

Neuropsychopharmacology
Chen BK, Custis T, Monteggia LM, George TP.   +3 more
europepmc   +1 more source

Engineering IL‐4 resistant proinflammatory human myeloid cells for cancer immunotherapy

Molecular Oncology, EarlyView.
We developed a scalable workflow to generate proinflammatory human myeloid cells. CRISPR/Cas9‐edited CD34+ hematopoietic stem and progenitor cells were expanded and differentiated with M‐CSF. Deletion of STAT6 or STAT6/NFKB1 enhanced macrophage proinflammatory gene expression and cytokine secretion in the presence of IL‐4 while maintaining antibody ...
Theresa Barberi, Alan D. Friedman
wiley   +1 more source

Spatial heterogeneity of hotspot mutations and clonal relatedness in ovarian endometrioid carcinoma

Molecular Oncology, EarlyView.
Spatially resolved analysis revealed heterogeneous distributions of selected cancer‐associated mutations within ovarian endometrioid carcinomas. Shared mutations between paired endometrial and ovarian tumors supported clonal relatedness. These findings highlight the value of sampling multiple tumor regions when interpreting molecular profiles ...
Takahito Ashihara, Kosuke Murakami, Shiro Takamatsu, Akiko Kanto, Seiichi Mori, Tomoyuki Otani, Kazuko Sakai, Yasushi Kotani, Kazuto Nishio, Kaoru Abiko, Noriomi Matsumura   +10 more
wiley   +1 more source

Open Access publishing practice in geochemistry: overview of current state and look to the future. [PDF]

Heliyon, 2020
Pourret O, Hursthouse A, Irawan DE, Johannesson K, Liu H, Poujol M, Tartèse R, van Hullebusch ED, Wiche O.   +8 more
europepmc   +1 more source

Author Reply Re: Jena R, Sharma AP, Madhavan K, Sridhar AN, Parmar K, Shrivastava N. What should urologists know about pseudojournals and open access publishing? A narrative review of the literature. Indian J Urol 2022;38:184-90. [PDF]

Indian J Urol, 2023
Jena R, Sharma AP, Madhavan K.
europepmc   +1 more source

Tumour‐proximal deep serum proteomics identifies biomarkers associated with ovarian cancer

Molecular Oncology, EarlyView.
New biomarkers are needed for early ovarian cancer detection. Ovarian (tumour‐proximal) and peripheral vein serum from healthy women and patients with benign or malignant tumours underwent nanoparticle‐enriched deep proteomics. Ovarian serum yielded more protein identifications and revealed tumour‐reflective signatures.
Darren Lau, Daniel Pincher, Clifford Young, Nicholas Chappell, Noor A. Lokman, Parul Mittal, Leigh Donnellan, Martin K. Oehler, Doug A. Brooks, Peter Hoffmann   +9 more
wiley   +1 more source

Does it pay to pay? A comparison of the benefits of open-access publishing across various sub-fields in biology. [PDF]

PeerJ
Clark AD, Myers TC, Steury TD, Krzton A, Yanes J, Barber A, Barry J, Barua S, Eaton K, Gosavi D, Nance R, Pervaiz Z, Ugochukwu C, Hartman P, Stevison LS.   +14 more
europepmc   +1 more source